These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23778908)

  • 41. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion.
    Tumialán LM; Rodts GE
    Spine J; 2007; 7(4):509-10. PubMed ID: 17526433
    [No Abstract]   [Full Text] [Related]  

  • 42. First reviews are published that are based on the "totality of the evidence".
    Kmietowicz Z
    BMJ; 2013 Jun; 346():f3909. PubMed ID: 23775921
    [No Abstract]   [Full Text] [Related]  

  • 43. Another complication associated with rhBMP-2?
    Kang JD
    Spine J; 2011 Jun; 11(6):517-9. PubMed ID: 21612984
    [No Abstract]   [Full Text] [Related]  

  • 44. Vertebral body osteolysis after minimal-access transforaminal interbody fusion.
    Lehman RA
    Spine J; 2011 Jun; 11(6):581-2. PubMed ID: 21729806
    [No Abstract]   [Full Text] [Related]  

  • 45. Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion.
    Christensen TJ; Annis P; Hohl JB; Patel AA
    Spine J; 2014 Jun; 14(6):e23-8. PubMed ID: 24291359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stand-alone anterior lumbar interbody fusion for degenerative disc disease of the lumbar spine: results with a 2-year follow-up.
    Lammli J; Whitaker MC; Moskowitz A; Duong J; Dong F; Felts L; Konye G; Ablah E; Wooley P
    Spine (Phila Pa 1976); 2014 Jul; 39(15):E894-901. PubMed ID: 24825156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. rh-BMP-2 can be used safely in the cervical spine: dose and containment are the keys!
    Dickerman RD; Reynolds AS; Morgan BC; Tompkins J; Cattorini J; Bennett M
    Spine J; 2007; 7(4):508-9. PubMed ID: 17521966
    [No Abstract]   [Full Text] [Related]  

  • 49. An evolving perception of the risk of rhBMP-2 use for anterior spinal interbody fusions.
    Smoljanovic T; Bojanic I
    Spine J; 2011 Jun; 11(6):520-1. PubMed ID: 21612986
    [No Abstract]   [Full Text] [Related]  

  • 50. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2.
    Villavicencio AT; Burneikiene S; Nelson EL; Bulsara KR; Favors M; Thramann J
    J Neurosurg Spine; 2005 Dec; 3(6):436-43. PubMed ID: 16381205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Under-reported complications related to BMP use in spine surgery.
    Aspenberg P
    Acta Orthop; 2011 Oct; 82(5):511-2. PubMed ID: 21992083
    [No Abstract]   [Full Text] [Related]  

  • 52. Anatomic feasibility of a new endopelvic approach for iliac crest bone harvesting.
    Le Pape S; Du Pouget L; Cloche T; Campana M; Obeid I; Boissiere L; Vital JM
    Surg Radiol Anat; 2016 Dec; 38(10):1191-1194. PubMed ID: 27160584
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT
    J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Commentary: Retrograde ejaculation and the use of rhBMP-2 for anterior lumbar interbody fusion: what does the evidence say to surgeons and to patients?
    Mroz TE; Abdullah KG; Benzel EC
    Spine J; 2012 Oct; 12(10):891-3. PubMed ID: 23199820
    [No Abstract]   [Full Text] [Related]  

  • 55. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
    Lubelski D; Abdullah KG; Nowacki AS; Alvin MD; Steinmetz MP; Chakka S; Li Y; Gajewski N; Benzel EC; Mroz TE
    J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".
    Bennett M; Reynolds AS; Dickerman RD
    Spine (Phila Pa 1976); 2006 Aug; 31(17):2029-30. PubMed ID: 16924224
    [No Abstract]   [Full Text] [Related]  

  • 57. Pseudo-Pedicle Heterotopic Ossification From Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Transforaminal Lumbar Interbody Fusion Cages.
    Rosen CD; Kiester PD; Lee TQ
    Am J Orthop (Belle Mead NJ); 2018 Jan; 47(1):. PubMed ID: 29447305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association Between BMP-2 and Carcinogenicity.
    Skovrlj B; Koehler SM; Anderson PA; Qureshi SA; Hecht AC; Iatridis JC; Cho SK
    Spine (Phila Pa 1976); 2015 Dec; 40(23):1862-71. PubMed ID: 26274524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
    Lehman RA; Kang DG
    Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
    [No Abstract]   [Full Text] [Related]  

  • 60. Iliac crest bone graft: are the complications overrated?
    Hu SS
    Spine J; 2011 Jun; 11(6):538-9. PubMed ID: 21729802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.